Inflammation

Myocardial infarction coincides with increased NOX2 and N^ε-(carboxymethyl) lysine expression in the cerebral microvasculature
Amber Korn, Umit Baylan, Suat Simsek, Casper G Schalkwijk, Hans W M Niessen, Paul A J Krijnen

Open Heart Nov 2021, 8 (2) e001842; DOI: 10.1136/openhrt-2021-001842
Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
Yasmin Miri, Karin Leander, Per Eriksson, Bruna Gigante, Louise Ziegler

Open Heart Oct 2021, 8 (2) e001694; DOI: 10.1136/openhrt-2021-001694
Periodontitis is associated to increased systemic inflammation in postmyocardial infarction patients
Ronaldo Lira-Junior, Elisabeth Almer Boström, Anders Gustafsson

Open Heart Aug 2021, 8 (2) e001674; DOI: 10.1136/openhrt-2021-001674
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
Ragnhild Helseth, Ola Kleveland, Thor Ueland, Rune Wiseth, Jan Kristian Damas, Kaspar Broch, Annika Michelsen, Bjørn Bendz, Lars Gullestad, Pål Aukrust, Ingebjørg Seljeflot

Open Heart May 2021, 8 (1) e001492; DOI: 10.1136/openhrt-2020-001492
Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management
Isabella D Cooper, Catherine A P Crofts, James J DiNicolantonio, Aseem Malhotra, Bradley Elliott, Yvoni Kyriakidou, Kenneth H Brookler

Open Heart Sep 2020, 7 (2) e001356; DOI: 10.1136/openhrt-2020-001356
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
James J DiNicolantonio, Jorge Barroso-Arranda, Mark McCarty

Open Heart Sep 2020, 7 (2) e001350; DOI: 10.1136/openhrt-2020-001350
Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Margrethe Flesvig Holt, Bjørn E Seim, Jonas Øgaard, Maria B Olsen, Per R Woldbæk, John-Peder Escobar Kvitting, Pål Aukrust, Arne Yndestad, Tom Eirik Mollnes, Per H Nilsson, Mieke C Louwe, Trine Ranheim

Open Heart Nov 2019, 6 (2) e001098; DOI: 10.1136/openhrt-2019-001098
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, Kaspar Broch, Bjørn Bendz, Svend Aakhus, Thor Ueland, Brage H Amundsen, Jan Kristian Damås, Einar Hopp, Ola Kleveland, Knut Haakon Stensæth, Anders Opdahl, Nils-Einar Kløw, Ingebjørg Seljeflot, Geir Øystein Andersen, Rune Wiseth, Pål Aukrust, Lars Gullestad

Open Heart Oct 2019, 6 (2) e001108; DOI: 10.1136/openhrt-2019-001108
Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
Colin G Stirrat, Shirjel Alam, Thomas J MacGillivray, Calum Gray, Marc Richard Dweck, Victor Jones, William Wallace, John R Payne, Sanjay K Prasad, Roy S Gardner, Mark C Petrie, Saeed Mirsadraee, Peter Henriksen, David E Newby, Scott Semple

Open Heart Oct 2019, 6 (2) e001115; DOI: 10.1136/openhrt-2019-001115
Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
Ben Alencherry, Geoffrey Erem, Grace Mirembe, Isaac Ssinabulya, Chun-Ho Yun, Chung-Lieh Hung, Mark J Siedner, Marcio Bittencourt, Cissy Kityo, Grace A McComsey, Chris T Longenecker

Open Heart May 2019, 6 (1) e001046; DOI: 10.1136/openhrt-2019-001046

Main menu

Inflammation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Inflammation

Pages